Sanmina, Adtran, Ameresco And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Benzinga
Published Nov 07, 2023 11:15
Updated Nov 07, 2023 12:40
Sanmina, Adtran, Ameresco And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Benzinga - by Lisa Levin, Benzinga Editor.
U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.
- Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares tumbled 74% to $3.66 in pre-market trading after the company announced efficacy results from the Phase 2 trial of VTX958 in plaque psoriasis did not meet the internal target to support further development of VTX958 in psoriasis.
- Alto Ingredients, Inc. (NASDAQ: ALTO) shares declined 52.4% to $2.34 in pre-market trading after the company reported mixed third-quarter financial results.
- Coherus BioSciences, Inc. (NASDAQ: CHRS) shares dipped 18.9% to $2.87 in pre-market trading after the company reported mixed third-quarter financial results.
- Ameresco, Inc. (NASDAQ: AMRC) shares declined 18.4% to $21.70 in pre-market trading following downbeat third-quarter results.
- Aura Biosciences, Inc. (NASDAQ: AURA) declined 15.5% to $9.30 in pre-market. Aura Biosciences priced its public offering of 11 million common shares at $9 per share.
- Clover Health Investments, Corp. (NASDAQ: CLOV) shares dropped 15.1% to $0.96 in pre-market trading following weak quarterly sales.
- Sanmina Corporation (NASDAQ: SANM) shares fell 12% to $46.50 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.
- Alpine Immune Sciences, Inc. (NASDAQ: ALPN) fell 9.4% to $12.80 in pre-market trading. Alpine Immune Sciences priced its $150 million public offering of 8.8 million common shares at $12.50 per share.
- ADTRAN Holdings, Inc. (NASDAQ: ADTN) shares fell 9.1% to $6.66 in pre-market trading following a wider-than-expected quarterly loss.
- Under Armour, Inc. (NYSE: UA) declined 8.3% to $6.11 in pre-market trading.
Don’t forget to check out our premarket coverage here
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Read the original article on Benzinga
Get The App
Written By: Benzinga
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.